Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran Added to Pregabalin in Fibromyalgia
NCT00797797Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of milnacipran in fibromyalgia (FM) (2 arms), sponsored by Forest Laboratories. Primary endpoint: Patient Global Impression of Change Responder Rate at 11 weeks. Started Nov 2008; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00797797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797797.